LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it ...
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NAS: SLP) , a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that the U ...
Simulations Plus, Inc. has announced that it has received a purchase order from the U.S. Food and Drug Administration to renew one of the licenses for the Company’s GastroPlus™ simulation software and ...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling & simulation solutions for the pharmaceutical, biotechnology, and chemicals industries, today ...
, a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that the U.S. Food and Drug Administration has added licenses of GastroPlus™ for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results